Mirion Technologies, Inc (NYSE:MIR) Momentum Signals Point To Near-Term Consolidation Despite Strategic Wins

Mirion shows operational and strategic momentum while price action and valuation metrics suggest short-term consolidation risk. Recent corporate partnerships and leadership moves reinforce execution focus even as liquidity and leverage paint a mixed picture.

Recent News

February 11, 2026 — Mirion announced three senior appointments, creating a Chief Nuclear Officer role, naming a President of Nuclear Medicine, and adding a Chief Artificial Intelligence & Digital Officer to accelerate nuclear strategy, medical-market development and enterprise AI initiatives. March 12, 2026 — Mirion confirmed selection as an official partner for World Engineering Day 2026, highlighting engineering and sustainable‑development engagement. March 24, 2026 — Mirion disclosed that its Crew Active Dosimeters will be carried by astronauts on NASA’s Artemis II mission for time‑resolved crew radiation monitoring.

Technical Analysis

ADX at 29.05 indicates a strong directional context; trend strength supports meaningful near‑term moves rather than range‑bound chop, which increases the potential impact of catalyst‑driven reactions.

DI+ shows a peak‑and‑reversal while DI+ sits at 17.85, a configuration that reads as a bearish signal because DI+ has rolled over. DI‑ sits at 27.16 and is decreasing, which reads as a bullish signal; the net directional picture therefore reflects competing forces rather than a clean trending bias.

MACD sits at -0.22 with a signal line at -0.39 and a clear cross of MACD above the signal line; the MACD increasing from negative territory signals a shift toward bullish momentum and constitutes a short‑term momentum pickup.

MRO registers 13.76 (positive and rising), indicating price currently trades above the model target and implying a higher probability of downward reversion pressure as that gap compresses.

RSI at 44.59 and rising shows recovery from lower levels but remains below neutral 50, implying bullish momentum exists but lacks conviction for a strong breakout until RSI moves above equilibrium.

Price sits below the 50‑day ($20.15) and 200‑day ($22.82) averages while trading near the 20‑day average ($19.42); the 12‑day EMA shows a peak‑and‑reversal, adding short‑term resistance to upside attempts and biasing near‑term moves toward consolidation or pullback rather than sustained rallies.

 


Fundamental Analysis

Earnings and cash flow: EPS came in at $0.15 versus a $0.16 estimate, an EPS surprise of -6.25%. Net income totaled $2.9M on $223.1M of revenue; operating income measured $7.4M and EBIT registered $10.1M. Free cash flow reached $13.0M, yielding a free‑cash‑flow yield of 0.23%.

Margins and growth: Gross margin sits at 46.84% while operating margin registers 3.32% and EBIT margin equals 4.53%. EBIT margin at 4.53% sits below the industry peer mean (15.13%) and industry peer median (19.51%). Reported revenue growth stands at 0.09% (minimal change). Quarter‑over‑quarter and year‑over‑year line items show divergence across categories; where available, QoQ and YoY values display notable volatility in short periods.

Liquidity and leverage: Current ratio equals 4.83x and quick ratio 4.32x, supported by cash and short‑term investments of $939.7M and a cash ratio of 3.27x, indicating substantial near‑term liquidity. Total debt equals $1,232.8M with net debt of $265.2M. Debt‑to‑EBITDA stands at roughly 27.4x, a leverage metric that materially elevates sensitivity to earnings variability and contrasts with the company’s strong cash position.

Returns and capital efficiency: Return on equity equals 0.157% and return on assets 0.093%, both very low and consistent with modest near‑term profitability scaling. Asset turnover sits at 0.0716, reflecting low revenue generated per dollar of assets. Interest coverage reads 1.13x, well below the industry peer mean (26.67x), indicating limited buffer against interest costs despite low stated cost of debt.

Valuation summary: WMDST values the stock as over‑valued. High multiples (for example, a reported PE ratio and elevated EV multiples) combined with modest earnings and pronounced leverage explain the WMDST valuation stance despite robust cash balances and high gross margin.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-09-30
REPORT DATE: 2026-02-10
NEXT REPORT DATE: 2026-05-12
CASH FLOW  Begin Period Cash Flow 263.0 M
 Operating Cash Flow 22.3 M
 Capital Expenditures -9.30 M
 Change In Working Capital -20.10 M
 Dividends Paid
 Cash Flow Delta 670.6 M
 End Period Cash Flow 933.6 M
 
INCOME STATEMENT REVENUE
 Total Revenue 223.1 M
 Forward Revenue 856.0 M
COSTS
 Cost Of Revenue 118.6 M
 Depreciation 34.9 M
 Depreciation and Amortization 34.9 M
 Research and Development 10.1 M
 Total Operating Expenses 215.7 M
PROFITABILITY
 Gross Profit 104.5 M
 EBITDA 45.0 M
 EBIT 10.1 M
 Operating Income 7.4 M
 Interest Income 2.2 M
 Interest Expense 8.9 M
 Net Interest Income -6.70 M
 Income Before Tax 1.2 M
 Tax Provision -1.90 M
 Tax Rate 21.0 %
 Net Income 2.9 M
 Net Income From Continuing Operations 3.1 M
EARNINGS
 EPS Estimate 0.16
 EPS Actual 0.15
 EPS Difference -0.01
 EPS Surprise -6.25 %
 Forward EPS 0.18
 
BALANCE SHEET ASSETS
 Total Assets 3.5 B
 Intangible Assets 1.9 B
 Net Tangible Assets -65.80 M
 Total Current Assets 1.4 B
 Cash and Short-Term Investments 939.7 M
 Cash 933.2 M
 Net Receivables 150.0 M
 Inventory 146.0 M
 Long-Term Investments 16.8 M
LIABILITIES
 Accounts Payable 49.4 M
 Short-Term Debt 1.6 M
 Total Current Liabilities 287.0 M
 Net Debt 265.2 M
 Total Debt 1.2 B
 Total Liabilities 1.6 B
EQUITY
 Total Equity 1.8 B
 Retained Earnings -530.00 M
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 7.35
 Shares Outstanding 250.750 M
 Revenue Per-Share 0.89
VALUATION
 Market Capitalization 5.7 B
 Enterprise Value 6.0 B
 Enterprise Multiple 132.544
Enterprise Multiple QoQ 35.978 %
Enterprise Multiple YoY 101.738 %
Enterprise Multiple IPRWA high: 185.353
MIR: 132.544
median: 76.114
mean: 72.692
low: -109.976
 EV/R 26.734
CAPITAL STRUCTURE
 Asset To Equity 1.899
 Asset To Liability 2.18
 Debt To Capital 0.401
 Debt To Assets 0.353
Debt To Assets QoQ 11.605 %
Debt To Assets YoY 153226.087 %
Debt To Assets IPRWA high: 1.311
MIR: 0.353
mean: 0.243
median: 0.153
low: 0.002
 Debt To Equity 0.67
Debt To Equity QoQ 13.173 %
Debt To Equity YoY 167282.5 %
Debt To Equity IPRWA high: 2.204
MIR: 0.67
mean: 0.408
median: 0.223
low: -1.277
PRICE-BASED VALUATION
 Price To Book (P/B) 3.08
Price To Book QoQ -2.272 %
Price To Book YoY 70.318 %
Price To Book IPRWA high: 15.33
median: 4.517
mean: 3.914
MIR: 3.08
low: -8.81
 Price To Earnings (P/E) 2264.512
Price To Earnings QoQ 244.539 %
Price To Earnings YoY 1431.821 %
Price To Earnings IPRWA MIR: 2264.512
high: 259.394
median: 101.806
mean: 95.026
low: -207.228
 PE/G Ratio -33.968
 Price To Sales (P/S) 25.421
Price To Sales QoQ 22.946 %
Price To Sales YoY 91.385 %
Price To Sales IPRWA high: 176.909
MIR: 25.421
mean: 22.217
median: 20.242
low: 0.307
FORWARD MULTIPLES
Forward P/E 136.437
Forward PE/G -2.047
Forward P/S 7.479
EFFICIENCY OPERATIONAL
 Operating Leverage -540.191
ASSET & SALES
 Asset Turnover Ratio 0.072
Asset Turnover Ratio QoQ -13.884 %
Asset Turnover Ratio YoY -8.606 %
Asset Turnover Ratio IPRWA high: 0.52
mean: 0.166
median: 0.135
MIR: 0.072
low: 0.0
 Receivables Turnover 1.527
Receivables Turnover Ratio QoQ -0.664 %
Receivables Turnover Ratio YoY 7.697 %
Receivables Turnover Ratio IPRWA high: 3.929
MIR: 1.527
mean: 1.485
median: 1.39
low: 0.148
 Inventory Turnover 0.815
Inventory Turnover Ratio QoQ -2.341 %
Inventory Turnover Ratio YoY 8.132 %
Inventory Turnover Ratio IPRWA high: 2.783
MIR: 0.815
mean: 0.765
median: 0.737
low: 0.001
 Days Sales Outstanding (DSO) 59.756
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 134.067
Cash Conversion Cycle Days QoQ -5.438 %
Cash Conversion Cycle Days YoY -8.355 %
Cash Conversion Cycle Days IPRWA high: 605.436
MIR: 134.067
mean: 131.535
median: 113.839
low: -371.003
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 0.203
 CapEx To Revenue -0.042
 CapEx To Depreciation -0.266
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 3.0 B
 Net Invested Capital 3.0 B
 Invested Capital 3.0 B
 Net Tangible Assets -65.80 M
 Net Working Capital 1.1 B
LIQUIDITY
 Cash Ratio 3.274
 Current Ratio 4.831
Current Ratio QoQ 89.853 %
Current Ratio YoY 123.312 %
Current Ratio IPRWA high: 13.125
MIR: 4.831
mean: 2.112
median: 1.703
low: 0.117
 Quick Ratio 4.323
Quick Ratio QoQ 114.832 %
Quick Ratio YoY 178.191 %
Quick Ratio IPRWA high: 7.703
MIR: 4.323
mean: 1.571
median: 1.243
low: 0.377
COVERAGE & LEVERAGE
 Debt To EBITDA 27.396
 Cost Of Debt 0.67 %
 Interest Coverage Ratio 1.135
Interest Coverage Ratio QoQ -31.679 %
Interest Coverage Ratio YoY 1354.724 %
Interest Coverage Ratio IPRWA high: 340.0
mean: 26.672
median: 19.017
MIR: 1.135
low: -401.025
 Operating Cash Flow Ratio 0.115
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 36.0
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate 27.686 %
 Revenue Growth 0.09 %
Revenue Growth QoQ -99.13 %
Revenue Growth YoY -162.069 %
Revenue Growth IPRWA high: 54.24 %
median: 2.034 %
mean: 2.004 %
MIR: 0.09 %
low: -45.858 %
 Earnings Growth -66.667 %
Earnings Growth QoQ -4.761 %
Earnings Growth YoY 233.335 %
Earnings Growth IPRWA high: 180.0 %
mean: 10.397 %
median: 3.175 %
MIR: -66.667 %
low: -100.918 %
MARGINS
 Gross Margin 46.84 %
Gross Margin QoQ 1.859 %
Gross Margin YoY 4.267 %
Gross Margin IPRWA high: 94.309 %
mean: 56.367 %
median: 55.361 %
MIR: 46.84 %
low: -37.943 %
 EBIT Margin 4.527 %
EBIT Margin QoQ -48.516 %
EBIT Margin YoY 750.94 %
EBIT Margin IPRWA high: 38.373 %
median: 19.512 %
mean: 15.128 %
MIR: 4.527 %
low: -908.773 %
 Return On Sales (ROS) 3.317 %
Return On Sales QoQ -25.31 %
Return On Sales YoY 523.496 %
Return On Sales IPRWA high: 34.618 %
median: 17.673 %
mean: 14.189 %
MIR: 3.317 %
low: -971.016 %
CASH FLOW
 Free Cash Flow (FCF) 13.0 M
 Free Cash Flow Yield 0.229 %
Free Cash Flow Yield QoQ 193.59 %
Free Cash Flow Yield YoY 61.268 %
Free Cash Flow Yield IPRWA high: 9.514 %
median: 0.995 %
mean: 0.812 %
MIR: 0.229 %
low: -42.542 %
 Free Cash Growth 261.111 %
Free Cash Growth QoQ -401.111 %
Free Cash Growth YoY -5452.829 %
Free Cash Growth IPRWA MIR: 261.111 %
high: 195.075 %
median: 43.065 %
mean: 17.324 %
low: -266.667 %
 Free Cash To Net Income 4.483
 Cash Flow Margin 14.747 %
 Cash Flow To Earnings 11.345
VALUE & RETURNS
 Economic Value Added 0.04
 Return On Assets (ROA) 0.093 %
Return On Assets QoQ -70.0 %
Return On Assets YoY -118.058 %
Return On Assets IPRWA high: 8.176 %
mean: 1.849 %
median: 1.844 %
MIR: 0.093 %
low: -70.984 %
 Return On Capital Employed (ROCE) 0.315 %
 Return On Equity (ROE) 0.002
Return On Equity QoQ -72.359 %
Return On Equity YoY -117.542 %
Return On Equity IPRWA high: 0.969
median: 0.029
MIR: 0.002
mean: -0.001
low: -1.516
 DuPont ROE 0.176 %
 Return On Invested Capital (ROIC) 0.262 %
Return On Invested Capital QoQ -61.185 %
Return On Invested Capital YoY -141.786 %
Return On Invested Capital IPRWA high: 18.508 %
mean: 3.204 %
median: 2.609 %
MIR: 0.262 %
low: -26.281 %

Six-Week Outlook

Expect range compression with a bias toward consolidation over the next six weeks as bullish momentum (MACD cross and rising RSI) competes with over‑valuation signals (WMDST valuation) and MRO indicating price sits above target. Strong liquidity reduces forced‑sell risk, but elevated debt‑to‑EBITDA and weak interest coverage magnify sensitivity to any operational slip. Near‑term price action should respond to execution headlines and order/backlog developments; technical momentum needs sustained follow‑through above short‑term averages to convert into a durable upside phase.

About Mirion Technologies, Inc.

Mirion Technologies, Inc. (NYSE:MIR) develops and delivers advanced radiation detection, measurement, analysis, and monitoring solutions across a global market. With operations spanning the United States, Canada, Europe, and Asia, Mirion caters to a diverse clientele including medical facilities, industrial companies, government agencies, and military organizations. The company organizes its offerings into two primary segments: Medical and Technologies. The Medical segment provides comprehensive solutions for radiation oncology quality assurance, dosimetry, and patient safety in diagnostic imaging and radiation therapy centers. It also offers products for radionuclide therapy, supporting applications in medical diagnostics, cancer treatment, and practitioner safety. The Technologies segment addresses critical radiation safety and measurement needs, supplying personal radiation detection and identification equipment, as well as analysis tools. Mirion’s extensive product portfolio includes nuclear medicines, dosimeters, contamination monitors, reactor instrumentation, and control systems. Additionally, the company offers medical and industrial imaging systems, alpha and gamma spectroscopy instruments, and various software solutions. Founded in 2005 and headquartered in Atlanta, Georgia, Mirion Technologies continues to serve a broad spectrum of industries, ensuring safety and precision in environments where radiation plays a critical role.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.